Kesimpta 20 MG/0.4 ML pen 0.4ML
Ended Awarded Last action
- Contract number
- SPE2DR26FYA9F
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $95,715
Award facts
- Contract value 100% obligated
- $95,714.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $95,714.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for KESIMPTA 20 mg/0.4 ml pen auto-injectors. The contract, executed on January 27, 2026, with a completion date of January 28, 2026, represents a competitively awarded non-set-aside delivery order supporting federal pharmaceutical procurement. This award falls under AmerisourceBergen's parent company Cencora, Inc.'s substantial $999.99 billion Indefinite Delivery Contract with DLA Troop Support Medical, which extends through December 2031 and serves as the primary vehicle for delivering comprehensive pharmaceutical and medical supplies to military healthcare programs globally.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor in the federal medical supply chain serving military and veteran healthcare systems. The delivery order for KESIMPTA, a neurological treatment medication, exemplifies the company's extensive portfolio of brand-name and generic pharmaceutical deliveries across multiple therapeutic domains. AmerisourceBergen's capacity to fulfill such orders through open competition and its position as a primary vendor for DLA demonstrates its significant role in supporting federal healthcare operations across treatment facilities, Defense Health Agency customers, and the U.S. Coast Guard.
Quick answers
Who was awarded contract SPE2DR26FYA9F?
SPE2DR26FYA9F was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26FYA9F worth?
The government has obligated $95,715 on SPE2DR26FYA9F.
Is contract SPE2DR26FYA9F an order under another contract?
Yes. SPE2DR26FYA9F is a delivery order under SPE2DR25D6044, an indefinite delivery contract.
Was contract SPE2DR26FYA9F competed?
The extent of competition for SPE2DR26FYA9F was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award